JAK2 rs10974944: Understanding the 46/1 Haplotype Association
The rs10974944 variant is a germline genetic marker located within the JAK2 gene. It is a key component of the 46/1 haplotype, which has been statistically associated with an increased predisposition to developing JAK2 V617F-positive myeloproliferative neoplasms.
What each genotype means
Average risk profile
This genotype represents the common, baseline state for this region of the JAK2 gene. It is not associated with the specific 46/1 haplotype that has been linked to an increased predisposition for certain myeloproliferative neoplasms.
This is the most common genotype observed in the general population.
Increased predisposition marker
This genotype indicates the presence of one copy of the 46/1 haplotype, which is statistically associated with a higher risk of developing JAK2 V617F-positive myeloproliferative neoplasms. This variant acts as a germline predisposition factor that may precede the acquisition of the somatic V617F mutation in blood cells.
This genotype is found in a significant portion of the population, with the G allele having a global minor allele frequency of approximately 25.67%.
Increased predisposition marker
This genotype indicates the presence of two copies of the 46/1 haplotype, which is statistically associated with a higher risk of developing JAK2 V617F-positive myeloproliferative neoplasms. Research suggests that the V617F mutation is preferentially acquired on the background of this specific haplotype.
This genotype is less common than the heterozygous state but is well-documented in populations where the 46/1 haplotype is prevalent.
What is rs10974944?
The rs10974944 variant is a single-nucleotide polymorphism (SNP) situated within the JAK2 gene, specifically located in intron 12. This variant serves as a reliable genetic tag for a specific group of inherited variations known as the 46/1 haplotype. A haplotype is a set of DNA variations that tend to be inherited together from a single parent. In the case of the 46/1 haplotype, it encompasses a region spanning from intron 10 to intron 15 of the JAK2 gene, including four distinct SNPs. Because rs10974944 is consistently found alongside these other variations, researchers use it as a proxy to identify individuals who carry the full 46/1 haplotype. It is important to note that this is a germline variant, meaning it is inherited from one's parents and is present in the DNA of most cells throughout the body, unlike somatic mutations which are acquired later in life.
The Role of the JAK2 Gene
The JAK2 gene provides instructions for making a protein called Janus kinase 2. This protein is a member of a family of enzymes that play a critical role in signaling pathways, particularly those involved in the production of blood cells from hematopoietic stem cells. By transmitting chemical signals from the cell surface to the nucleus, the JAK2 protein helps regulate cell growth, division, and survival. When the JAK2 signaling pathway is functioning correctly, it ensures that the body produces the appropriate number of red blood cells, white blood cells, and platelets. However, when the JAK2 gene is altered—either through inherited germline variations or acquired somatic mutations—it can lead to dysregulated signaling. This disruption is a hallmark of myeloproliferative neoplasms (MPNs), a group of conditions where the bone marrow produces too many blood cells.
Research and Associations
Scientific research has established a strong statistical association between the 46/1 haplotype (tagged by the G allele of rs10974944) and the acquisition of the somatic JAK2 V617F mutation. The V617F mutation is an acquired change found in the majority of patients with polycythemia vera, essential thrombocythemia, and primary myelofibrosis. Studies have shown that the V617F mutation is significantly more likely to occur on a chromosome that already carries the 46/1 haplotype. While this suggests that the 46/1 haplotype may create a genetic environment that makes the acquisition of the V617F mutation more likely, it is not a direct cause of disease on its own. The evidence for this predisposition is considered moderate, as many individuals carry the 46/1 haplotype without ever developing an MPN, and many MPN cases occur without this specific genetic background.
Understanding Your Results
If you have information regarding your rs10974944 genotype, it is important to view it in the proper context. This variant is a marker of genetic predisposition, not a diagnostic test for a blood disorder. The presence of the G allele does not mean an individual will develop a myeloproliferative neoplasm, nor does the absence of it guarantee protection. Because the vast majority of people with this variant remain healthy, it is not used as a clinical screening tool for the general population. If you are concerned about your blood counts or have a family history of blood disorders, the most appropriate step is to consult with a healthcare professional or a hematologist. They can evaluate your clinical symptoms, blood work, and medical history to determine if any further testing is necessary. Never use genetic information to make personal health decisions without professional medical guidance.
How common is this variant?
The G allele of rs10974944 is relatively common, with a global minor allele frequency (GMAF) of approximately 0.2567. The 46/1 haplotype is found in roughly 24% of the general population.
Frequently asked questions
Does having the rs10974944 G allele mean I have a blood cancer?
No. The rs10974944 variant is a germline marker associated with a predisposition to certain conditions, not a diagnosis of cancer. Most people who carry this variant will never develop a myeloproliferative neoplasm.
What is the difference between rs10974944 and JAK2 V617F?
rs10974944 is an inherited (germline) variant that you are born with. JAK2 V617F is an acquired (somatic) mutation that typically occurs later in life within specific blood cells.
Should I get tested for this variant?
There is no clinical recommendation for the general population to be tested for this variant. It is primarily used in research settings to study the genetic architecture of blood disorders.
Can I change my risk if I have this genotype?
Because this is an inherited genetic marker, it cannot be changed. Genetic predisposition is only one factor in health, and you should focus on maintaining overall wellness and discussing any specific health concerns with your doctor.
Sources & further reading
Educational information only, last refreshed 9/24/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs10974944?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29